Investing Profile

James W. Brush

InvestorVC

General Partner and Portfolio Manager at Frazier Life Sciences

Your Intro Paths to James W. Brush

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks James is a member of

Boston Consulting Group (BCG) Network

437 CONNECTIONS

Harvard Medical School Network

72 CONNECTIONS

The Boston Consulting Group Network

52 CONNECTIONS

Beth Israel Deaconess Medical Center Network

11 CONNECTIONS

Find James W. Brush on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

James W. Brush is on these Sector & Stage Rankings

James W. Brush's Investments On Record (2)

Company	StageDateRound Size	Total Raised
Maze Therapeutics	Post Ipo EquityApr 2026$150M Post Ipo EquitySep 2025$150M Series DDec 2024$120M	$800M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Jonathan Lim (SignalFire), Elena Viboch (General Catalyst), Brendan Bulik-Sullivan (GV (Google Ventures)), Andy Tran (Matrix Capital Management Company, L.P.), Charles Homcy (Third Rock Ventures), Jonathan Lim (ARCH Venture Partners)
Amunix	Series BMar 2021$120M Series AMar 2020$73M	$190M

James W. Brush's Experience

General Partner and Portfolio Manager Frazier Life Sciences2016 - Present

Consultant Boston Consulting Group (BCG)Present

Consultant The Boston Consulting Group2014 - 2016

Resident in Internal Medicine, Harvard Medical School Beth Israel Deaconess Medical Center2011 - 2014

Research Assistant Harvard Medical School2005 - 2007

Investors who invest with James W. Brush

Scouts & Angels Affiliated With James W. Brush